Cargando…
Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes
BACKGROUND: Increasing the permeability of the zona pellucida (ZP) of oocytes before CRISPR/Cas9 electroporation may improve the efficiency of gene editing; however, the effects of this approach on subsequent developmental processes are unclear. In this study, the effects of ZP treatment before elec...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788957/ https://www.ncbi.nlm.nih.gov/pubmed/34674375 http://dx.doi.org/10.1002/vms3.659 |
_version_ | 1784639660872433664 |
---|---|
author | Namula, Zhao Hirata, Maki Le, Quynh Anh Lin, Qingyi Takebayashi, Koki Yoshimura, Naoaki Tanihara, Fuminori Thongkittidilok, Chommanart Otoi, Takeshige |
author_facet | Namula, Zhao Hirata, Maki Le, Quynh Anh Lin, Qingyi Takebayashi, Koki Yoshimura, Naoaki Tanihara, Fuminori Thongkittidilok, Chommanart Otoi, Takeshige |
author_sort | Namula, Zhao |
collection | PubMed |
description | BACKGROUND: Increasing the permeability of the zona pellucida (ZP) of oocytes before CRISPR/Cas9 electroporation may improve the efficiency of gene editing; however, the effects of this approach on subsequent developmental processes are unclear. In this study, the effects of ZP treatment before electroporation on embryonic development and gene editing in porcine embryos were evaluated. METHODS: The ZP of zygotes was weakened or removed by exposure to 0.5% actinase E, followed by electroporation of the Cas9 protein with guide RNA targeting GGTA1. RESULTS: The blastocyst formation rate of ZP‐free zygotes after electroporation was significantly lower (p < 0.05) than that of ZP‐intact zygotes. The mutation rate in blastocysts from ZP‐weakened zygotes was similar to that in ZP‐intact zygotes, whereas ZP removal increased the mutation rate. The mutation efficiency in blastocysts from electroporated zygotes did not differ among ZP treatment groups. CONCLUSIONS: Our results indicate that weakening the ZP does not affect the developmental competence, mutation rate, or mutation efficiency of electroporated zygotes, whereas ZP removal has a detrimental effect on embryonic development but may increase the mutation rate. |
format | Online Article Text |
id | pubmed-8788957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87889572022-02-01 Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes Namula, Zhao Hirata, Maki Le, Quynh Anh Lin, Qingyi Takebayashi, Koki Yoshimura, Naoaki Tanihara, Fuminori Thongkittidilok, Chommanart Otoi, Takeshige Vet Med Sci PIGS BACKGROUND: Increasing the permeability of the zona pellucida (ZP) of oocytes before CRISPR/Cas9 electroporation may improve the efficiency of gene editing; however, the effects of this approach on subsequent developmental processes are unclear. In this study, the effects of ZP treatment before electroporation on embryonic development and gene editing in porcine embryos were evaluated. METHODS: The ZP of zygotes was weakened or removed by exposure to 0.5% actinase E, followed by electroporation of the Cas9 protein with guide RNA targeting GGTA1. RESULTS: The blastocyst formation rate of ZP‐free zygotes after electroporation was significantly lower (p < 0.05) than that of ZP‐intact zygotes. The mutation rate in blastocysts from ZP‐weakened zygotes was similar to that in ZP‐intact zygotes, whereas ZP removal increased the mutation rate. The mutation efficiency in blastocysts from electroporated zygotes did not differ among ZP treatment groups. CONCLUSIONS: Our results indicate that weakening the ZP does not affect the developmental competence, mutation rate, or mutation efficiency of electroporated zygotes, whereas ZP removal has a detrimental effect on embryonic development but may increase the mutation rate. John Wiley and Sons Inc. 2021-10-21 /pmc/articles/PMC8788957/ /pubmed/34674375 http://dx.doi.org/10.1002/vms3.659 Text en © 2021 The Authors. Veterinary Medicine and Science published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | PIGS Namula, Zhao Hirata, Maki Le, Quynh Anh Lin, Qingyi Takebayashi, Koki Yoshimura, Naoaki Tanihara, Fuminori Thongkittidilok, Chommanart Otoi, Takeshige Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes |
title | Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes |
title_full | Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes |
title_fullStr | Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes |
title_full_unstemmed | Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes |
title_short | Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes |
title_sort | zona pellucida treatment before crispr/cas9‐mediated genome editing of porcine zygotes |
topic | PIGS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788957/ https://www.ncbi.nlm.nih.gov/pubmed/34674375 http://dx.doi.org/10.1002/vms3.659 |
work_keys_str_mv | AT namulazhao zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes AT hiratamaki zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes AT lequynhanh zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes AT linqingyi zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes AT takebayashikoki zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes AT yoshimuranaoaki zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes AT taniharafuminori zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes AT thongkittidilokchommanart zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes AT otoitakeshige zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes |